RE:RE:Strong BuyWe have our deal, funding from the Boston Group through the start of human dosage. They have deep pockets and one of them is involved on a nearly daily basis with Promis to ensure progress toward the goals.It is a simple story of execution from here. Get the consolidation of shares done and get a US stock listing, make a filing for human clinical trials of PMN 310 then begin human dosage.
Think about it, we are partnered with an amazing and successful group of business people who have an interest in ALZ, one of them founded the Alzheimer's Fund. They did their due diligence. Ask yourself, does this stock stay stuck at a $40M market cap through a bunch of good news through the beginning of human clinical trials or does it take off. The shares are going to be shrunk by a factor of 60, less supply. The market will be completely opened up to US institutional investors. Think about the risk and reward of owning this stock for another eight months.